Imunon, Inc. - 10-Q Filing
Imunon filed a Form 10-Q quarterly report for the period ended March 31, 2026. The filing includes unaudited financial statements showing total cash and equivalents of $5.8 million as of March 31, 2026, compared to $7.4 million at December 31, 2025. Operating expenses for the first quarter were $9.1 million versus $8.6 million in the same period last year.
Tickers: $IMNN